Result Summary for APV30005
| Protocol ID: | APV30005 |
| Clinical Study ID: | APV30005 |
| Official Title: | An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | Telzer,Telzir,Lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: | Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.

Click
here to download result summary.